Koselugo (selumetinib) for the Treatment of Neurofibromatosis Type 1 (NF1)

Image 3-Koselugo
Neurofibromatosis 1 occurs due to mutations in the NF1 gene found on chromosome 17. Credit: Shutterstock + David A Litman